Genetic privacy — Executive director Pam Dixon presented key issues and potential solutions regarding privacy and Genome Wide Association Studies at the Institute of Medicine’s Board on Health Sciences Policy meeting. Her presentation included recommendations to engage in a comprehensive study of certificates of confidentiality, to encourage standards of identifiability, to encourage study of what more uniform standards of privacy and security for researchers might look like, and a recommendation to work toward broad solutions that extend beyond GWAS activities.

AHIC – National Health Information Network — The American Health Information Community Workgroup on Confidentiality, Privacy and Security requested public feedback regarding its working hypothesis. WPF responded to the request with public comments encouraging the adoption of a unified policy architecture and encouraging AHIC to focus on enforcement mechanisms that are intended to directly benefit consumers. WPF also encouraged AHIC to look comprehensively at the demands a new national electronic health exchange network will make on privacy in the health care sector.

The American Health Information Community Workgroup on Confidentiality, Privacy and Security requested public feedback regarding its working hypothesis. WPF responded to the request with public comments encouraging the adoption of a unified policy architecture and encouraging AHIC to focus on enforcement mechanisms that are intended to directly benefit consumers. WPF also encouraged AHIC to look comprehensively at the demands a new national electronic health exchange network will make on privacy in the health care sector.

information will expand greatly in the future. In public comments filed with the National Institutes of Health on pharmacogenomics (PGx) research, or research using genetic information to create highly personalized medicine, the World Privacy Forum recommended that all research activities that involve any type of patient-specific genetic information be required to have certificates of confidentiality, whether that information appears identifiable or not. The WPF also urged the NIH to require strong data use agreements to protect individuals’ privacy. The WPF also urged NIH and the Department of Health and Human Services to reinstate the position of “privacy advocate” so as to provide oversight in this area.

The World Privacy Forum believes that the capability of identifying individuals from subsets of genetic information will expand greatly in the future. In public comments filed with the National Institutes of Health on pharmacogenomics (PGx) research, or research using genetic information to create highly personalized medicine, the World Privacy Forum recommended that all research activities that involve any type of patient-specific genetic information be required to have certificates of confidentiality, whether that information appears identifiable or not. The WPF also urged the NIH to require strong data use agreements to protect individuals’ privacy. The WPF also urged NIH and the Department of Health and Human Services to reinstate the position of “privacy advocate” so as to provide oversight in this area. Read the comments (PDF). For more information, see the genetic section of the WPF Medical Privacy Page.